Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Dermatology CRO market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Dermatology CRO market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Dermatology CRO market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Dermatology CRO products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Dermatology CRO products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Dermatology CRO market.
To learn more about this report
Increasing research and development spending on Dermatology CRO development has been the leading industry trend of Dermatology CRO market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Drug Discovery, Preclinical, Clinical, Other |
| By Application Outlook | Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and Site Recruitment, Technology, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | IQVIA HOLDINGS INC., Covance Inc., Pharmaceutical Product Development, LLC (PPD), Parexel International Corporation, Charles River Laboratories International, Inc., Icon, Plc, Medidata Solutions, Inc., Syneos Health, Pharmaron, GVK Biosciences Private Limited, Wuxi AppTec, MEDPACE HOLDINGS, INC., PRA Health Sciences, CTI Clinical Trial & Consulting, Bioskin, Proinnovera, Biorasi, Javara, TFS |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Dermatology CRO Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Dermatology CRO Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Dermatology CRO Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Dermatology CRO Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Drug Discovery
4.2.2 Preclinical
4.2.3 Clinical
4.2.4 Other
4.4 Type Comparison Matrix
4.5 Global Dermatology CRO Market Attractiveness, By Type
5 Global Dermatology CRO Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Dermatology CRO Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Project Management/Clinical Supply Management
5.3.2 Data Management
5.3.3 Regulatory/Medical Affairs
5.3.4 Medical Writing
5.3.5 Clinical Monitoring
5.3.6 Quality Management/Assurance
5.3.7 Bio-statistics
5.3.8 Investigator Payments
5.3.9 Laboratory
5.3.10 Patient and Site Recruitment
5.3.11 Technology
5.3.12 Others
5.4 Application Comparison Matrix
5.5 Global Dermatology CRO Market Attractiveness, by Application
6 Global Dermatology CRO Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Dermatology CRO Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Dermatology CRO Market Attractiveness, by Region
8 North America Dermatology CRO Market Analysis and Forecast
8.1 Key Findings
8.2 North America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Drug Discovery
8.2.2 Preclinical
8.2.3 Clinical
8.2.4 Other
8.3 North America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Project Management/Clinical Supply Management
8.3.2 Data Management
8.3.3 Regulatory/Medical Affairs
8.3.4 Medical Writing
8.3.5 Clinical Monitoring
8.3.6 Quality Management/Assurance
8.3.7 Bio-statistics
8.3.8 Investigator Payments
8.3.9 Laboratory
8.3.10 Patient and Site Recruitment
8.3.11 Technology
8.3.12 Others
8.4 North America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Dermatology CRO Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Dermatology CRO Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Drug Discovery
9.2.2 Preclinical
9.2.3 Clinical
9.2.4 Other
9.3 Europe Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Project Management/Clinical Supply Management
9.3.2 Data Management
9.3.3 Regulatory/Medical Affairs
9.3.4 Medical Writing
9.3.5 Clinical Monitoring
9.3.6 Quality Management/Assurance
9.3.7 Bio-statistics
9.3.8 Investigator Payments
9.3.9 Laboratory
9.3.10 Patient and Site Recruitment
9.3.11 Technology
9.3.12 Others
9.4 Europe Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Dermatology CRO Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Dermatology CRO Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Drug Discovery
10.2.2 Preclinical
10.2.3 Clinical
10.2.4 Other
10.3 Asia Pacific Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Project Management/Clinical Supply Management
10.3.2 Data Management
10.3.3 Regulatory/Medical Affairs
10.3.4 Medical Writing
10.3.5 Clinical Monitoring
10.3.6 Quality Management/Assurance
10.3.7 Bio-statistics
10.3.8 Investigator Payments
10.3.9 Laboratory
10.3.10 Patient and Site Recruitment
10.3.11 Technology
10.3.12 Others
10.4 Asia Pacific Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Dermatology CRO Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Dermatology CRO Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Drug Discovery
11.2.2 Preclinical
11.2.3 Clinical
11.2.4 Other
11.3 Latin America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Project Management/Clinical Supply Management
11.3.2 Data Management
11.3.3 Regulatory/Medical Affairs
11.3.4 Medical Writing
11.3.5 Clinical Monitoring
11.3.6 Quality Management/Assurance
11.3.7 Bio-statistics
11.3.8 Investigator Payments
11.3.9 Laboratory
11.3.10 Patient and Site Recruitment
11.3.11 Technology
11.3.12 Others
11.4 Latin America Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Dermatology CRO Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Dermatology CRO Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Drug Discovery
12.2.2 Preclinical
12.2.3 Clinical
12.2.4 Other
12.3 Middle East & Africa (MEA) Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Project Management/Clinical Supply Management
12.3.2 Data Management
12.3.3 Regulatory/Medical Affairs
12.3.4 Medical Writing
12.3.5 Clinical Monitoring
12.3.6 Quality Management/Assurance
12.3.7 Bio-statistics
12.3.8 Investigator Payments
12.3.9 Laboratory
12.3.10 Patient and Site Recruitment
12.3.11 Technology
12.3.12 Others
12.4 Middle East & Africa (MEA) Dermatology CRO Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Dermatology CRO Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 IQVIA HOLDINGS INC.
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Covance Inc.
13.3.3 Pharmaceutical Product Development
13.3.4 LLC (PPD)
13.3.5 Parexel International Corporation
13.3.6 Charles River Laboratories International
13.3.7 Inc.
13.3.8 Icon
13.3.9 Plc
13.3.10 Medidata Solutions
13.3.11 Inc.
13.3.12 Syneos Health
13.3.13 Pharmaron
13.3.14 GVK Biosciences Private Limited
13.3.15 Wuxi AppTec
13.3.16 MEDPACE HOLDINGS
13.3.17 INC.
13.3.18 PRA Health Sciences
13.3.19 CTI Clinical Trial & Consulting
13.3.20 Bioskin
13.3.21 Proinnovera
13.3.22 Biorasi
13.3.23 Javara
13.3.24 TFS
14 Key Takeaways
Choose License Type